adds that the Federal Trade Commission, which has been pushing for the change, is working with the manufacturers to help the market figure out the rules.
This is a very important and timely issue that will have significant benefits to the health and safety of the American people, said Dr. Scott Gottlieb, the FTC’s chief executive.
The Commission will continue to work with industry to find a solution, he said.
The FTC expects to announce its decision by mid-November.
For the past year, the FCC has been working with medical device makers to establish guidelines on the sale of medical device inventory in the U.S.
The commission’s rules are a first step to making medical devices more readily available to consumers.
But they won’t make a dent in a national problem of chronic, unnecessary, and expensive prescription drug use, according to a report in the New York Times.
The commission is also considering whether to allow manufacturers to sell the devices directly to the consumer.
“If you are the owner of a device, and you want to sell it to someone who wants to buy it, then you’re going to be forced to sell that device to someone else,” said Peter Hirsch, a professor of health policy at New York University.
“So the only way to sell your device is to go through the system.”